Increased Risk of Colorectal Cancer Tied to Advanced Colorectal Polyps: An Untapped Opportunity to Screen First-Degree Relatives and Decrease Cancer Burden

Gastrointestinal Cancer

Telephone versus in-person colorectal cancer risk and screening intervention for first-degree relatives: A randomized controlled trial

Cancer.

Esplen MJ, Harrington S, Leung YW, Aronson M, Rothenmund H, Semotiuk K, Wong J, Gallinger S, Dicks E, McLaughlin J

doi: 10.1002/cncr.32032.

Colonoscopy

Clinical Practice Guideline on Screening for Colorectal Cancer in individuals with a Family History of Nonhereditary Colorectal Cancer or Adenoma: The Canadian Association of Gastroenterology Banff Consensus

Gastroenterology.

Leddin D, Lieberman DA, Tse F, Barkun AN, Abou-Setta AM, Marshall JK, Samadder NJ, Singh H, Telford JJ, Tinmouth J, Wilkinson AN, Leontiadis GI

doi: 10.1053/j.gastro.2018.08.017.

Colonoscopy

Predicting the presence of adenomatous polyps during colonoscopy with National Cancer Institute Colorectal Cancer Risk-Assessment Tool

World J Gastroenterol.

Tariq H, Kamal MU, Patel H, Patel R, Ameen M, Elona S, Khalifa M, Azam S, Zhang A, Kumar K, Baiomi A, Shaikh D, Makker J

doi: 10.3748/wjg.v24.i34.3919.

Colonoscopy

Long-term Risk of Colorectal Cancer and Related Deaths After a Colonoscopy With Normal Findings

doi: 10.1001/jamainternmed.

ColonoscopyGastrointestinal Cancer

Head-to-Head Comparison of the Performance of 17 Risk Models for Predicting Presence of Advanced Neoplasms in Colorectal Cancer Screening

Am J Gastroenterol.

Peng L, Balavarca Y, Weigl K, Hoffmeister M, Brenner H

doi: 10.14309/ajg.0000000000000370.

ColonoscopyGastrointestinal Cancer

Risk-Adapted Cutoffs in Colorectal Cancer Screening by Fecal Immunochemical Tests

Am J Gastroenterol.

Peng L, Balavarca Y, Niedermaier T, Weigl K, Hoffmeister M, Brenner H

doi: 10.14309/ajg.

ColonoscopyGastrointestinal Cancer

Long-term Risk of Colorectal Cancer After Removal of Conventional Adenomas and Serrated Polyps

Gastroenterology.

He X, Hang D, Wu K, Nayor J, Drew DA, Giovannucci EL, Ogino S, Chan AT, Song M

doi: 10.1053/j.gastro.2019.06.039.

Gastrointestinal Cancer

Incidence of Interval Colorectal Cancer After Negative Results From First-round Fecal Immunochemical Screening Tests, by Cutoff Value and Participant Sex and Age

Clin Gastroenterol Hepatol.

Toes-Zoutendijk E, Kooyker AI, Dekker E, Spaander MCW, Opstal-van Winden AWJ, Ramakers C, Buskermolen M, van Vuuren AJ, Kuipers EJ, van Kemenade FJ, Velthuysen MF, Thomeer MGJ, van Veldhuizen H, van Ballegooijen M, Nagtegaal ID, de Koning HJ, van Leerdam ME, Lansdorp-Vogelaar I, Dutch national colorectal cancer screening working group.

doi: 10.1016/j.cgh.2019.08.021.

Gastrointestinal Cancer

Evaluating the effects of a risk-adapted screening program for familial colorectal cancer in individuals between 25 and 50 years of age: study protocol for the prospective population-based intervention study FARKOR

BMC Gastroenterol.

Hoffmann S, Crispin A, Lindoerfer D, Sroczynski G, Siebert U, Mansmann U, Consortium F

doi: 10.1186/s12876-020-01247-6.

Related content

Telephone versus in-person colorectal cancer risk and screening intervention for first-degree relatives: A randomized controlled trial

Clinical Practice Guideline on Screening for Colorectal Cancer in individuals with a Family History of Nonhereditary Colorectal Cancer or Adenoma: The Canadian Association of Gastroenterology Banff Consensus

Predicting the presence of adenomatous polyps during colonoscopy with National Cancer Institute Colorectal Cancer Risk-Assessment Tool

Long-term Risk of Colorectal Cancer and Related Deaths After a Colonoscopy With Normal Findings

Head-to-Head Comparison of the Performance of 17 Risk Models for Predicting Presence of Advanced Neoplasms in Colorectal Cancer Screening

Risk-Adapted Cutoffs in Colorectal Cancer Screening by Fecal Immunochemical Tests

Long-term Risk of Colorectal Cancer After Removal of Conventional Adenomas and Serrated Polyps

Incidence of Interval Colorectal Cancer After Negative Results From First-round Fecal Immunochemical Screening Tests, by Cutoff Value and Participant Sex and Age

Evaluating the effects of a risk-adapted screening program for familial colorectal cancer in individuals between 25 and 50 years of age: study protocol for the prospective population-based intervention study FARKOR